Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
QingSong HealthHKSE:02661 +2.60%18 Days Payable is 14.66 as of Dec. 2025, which is 80% below its 10-year median of 74.23. GuruFocus rates HKSE:02661 with a GF Score™ of 18/100. The stock has 4 warning signs investors should review. Among 606 Healthcare Providers & Services companies, QingSong Health ranks worse than 86.14% on this metric.
The historical rank and industry rank for QingSong Health's Days Payable or its related term are showing as below:
HKSE:02661'
s Days Payable Range Over the Past 10 Years
Min: 16.08 Med: 74.23 Max: 146.53
Current: 16.08
During the past 4 years, QingSong Health's highest Days Payable was 146.53. The lowest was 16.08. And the median was 74.23.
HKSE:02661's Days Payable is ranked worse than 86.14% of 606
companies
in the Healthcare Providers & Services industry
Industry Median: 57.015
vs HKSE:02661: 16.08
QingSong Health's Days Payable
declined
from Dec. 2024 (22.06) to Dec. 2025 (14.66).
It may suggest that QingSong Healthaccelerated paying its suppliers.
The historical data trend for QingSong Health's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02661 vs VEEV, BTSG, HQY: Days Payable Comparison
For the Health Information Services subindustry, QingSong Health's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
QingSong Health Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, QingSong Health's Days Payable distribution charts can be found below:
* The bar in red indicates where QingSong Health's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
QingSong Health's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
QingSong Health (HKSE:02661) has a Days Payable of 14.66 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on QingSong Health and its competitors. This is 80% below median its historical median of 74.23. Over the past decade, QingSong Health's Days Payable has ranged from 16.08 to 146.53. According to the industry distribution chart, QingSong Health ranks #522 out of 606 companies in the Healthcare Providers & Services industry, placing it in the top 86.1%.
Is QingSong Health's Days Payable too high?
QingSong Health's current Days Payable of 14.66 is 80% below median its 10-year median of 74.23. Over the past 10 years, this metric has ranged from a low of 16.08 to a high of 146.53. The Healthcare Providers & Services industry median Days Payable is 57.02. QingSong Health's value of 14.66 is 74.3% below this industry median. Based on the distribution chart, QingSong Health ranks #522 out of 606 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, QingSong Health has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does QingSong Health's Days Payable compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, QingSong Health ranks #522 out of 606 companies for Days Payable. This places QingSong Health in the lower half of its industry. The industry median Days Payable is 57.02. QingSong Health's value of 14.66 is 74.3% below this benchmark. Historically, QingSong Health's own Days Payable has ranged from 16.08 to 146.53 over the past decade. While the company's 10-year median is 74.23 vs. the industry median of 57.02, QingSong Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.02, based on 606 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. QingSong Health's current Days Payable of 14.66 is 74.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on QingSong Health and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. QingSong Health's current Days Payable is 14.66, which is 80% below median its own 10-year median of 74.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is QingSong Health stock overvalued right now?
QingSong Health (HKSE:02661) has a current Days Payable of 14.66. The current Days Payable is 14.66, which is 80% below median its 10-year median of 74.23 and 74.3% below the Healthcare Providers & Services industry median of 57.02. QingSong Health's overall GF Score™ is 18/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For QingSong Health (HKSE:02661), the current Days Payable is 14.66 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
QingSong Health Corp is a technology-driven one-stop platform in China, focusing on providing comprehensive health services and health insurance solutions. It offers healthcare-related services, including early disease screening promotion and consultancy, health examinations and consultations, medical appointment services, and the sale of health supplements. It prominently offers health insurance products providing coverage for illness and medical expenses, typically for one year or less. The company also offers critical illness insurance, which provides a lump-sum payment if the policyholder is diagnosed with specified serious illnesses. It derives revenue from the provision of Healthcare-related Services. Geographically, it operates only in China.
18GF Score
Get the complete analysis for HKSE:02661
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02661 has been successfully added to your 
